How Trump Could Build an Autocracy:
A Conversation with David Frum and Scott Stossel

February 16, 2017
Washington, DC

Hosted in Partnership With

Sixth & I

Over the past generation, we have seen ominous indicators of a breakdown of the American political system,” writes David Frum in his cover story “How to Build an Autocracy” in the latest issue of The Atlantic.

The piece comes at a critical time in our history, as a confluence of factors have made the country’s democratic institutions ripe on what some would say is perilous footing. As President Trump implements his agenda for the country, Frum writes, it will be up to the public and to Congress to push for checks and balances.

As part of The Atlantic's ongoing partnership with Sixth & I, Frum, a former speechwriter for President George W. Bush, joined The Atlantic Editor Scott Stossel to discuss why he believes President Trump could lead our democracy to an autocracy, and what it could mean for the future of the Republic.


Watch the full interview

Sixth & I
600 I Street, NW
Washington, DC 20001

For more information, please contact Katie Yost at kyost@theatlantic.com

Presented by

Atlantic Live

Speakers

Hosted in Partnership With

Also in This Series

Upcoming Events

  • Technology

    Franklin Foer In Conversation
    with Hanna Rosin

    Franklin Foer will join Hanna Rosin for a conversation about his new book World Without Mind and how consolidation of knowledge and information has changed how we contemplate the world.

  • Health Care

    Children and Cancer:
    An Atlantic Forum

    The Atlantic will break down the latest in immunotherapy and how it is being used to help young patients survive and thrive. And moving beyond anecdotal evidence, we'll examine how can big data can be used to track how pediatric cancers impact aspects of health for survivors down the road.

  • Health Care

    Cancer and the Community

    The Atlantic will explore challenges such as Nevada's shortage of doctors and specialists and learn what can be done from researchers, experts, stakeholders, survivors and patients living with cancer.